Prevalence of sexually
transmitted infections and performance of STI syndromes against
aetiological diagnosis, in female sex workers of red light area in
Surat, India
http://sti.bmjjournals.com/cgi/content/full/79/2/111
V K Desai1, J K Kosambiya1,
H G Thakor1, D D Umrigar2, B R Khandwala3
and K K Bhuyan4
1
Department of Community Medicine, Government Medical College, Surat,
India
2 Skin & VD Department, GMCS, Surat, India
3 Khandwala Clinical Laboratory, Surat, India
4 Family Health International
Correspondence to:
Dr (Mrs) Vikas K Desai, Community Medicine Department, Government
Medical College (GMCS), Surat, Majura gate, Surat, Gujarat, India;
psmvikas@hotmail.com
Accepted for publication 10
October 2002
ABSTRACT
Objectives: To measure prevalence of selected sexually
transmitted infections (STI) and HIV among female sex
workers (SWs) in the red light area of Surat, India, and
to evaluate the performance of STI syndrome guidelines
(for general population women in India) in this group
against the standard aetiological diagnosis of STIs by
laboratory methods.
Methods: In a cross sectional study, 124 out of an
estimated total of 500 SWs were mobilised to a health
camp near the red light area during 2000. After obtaining
consent, a behavioural questionnaire was administered,
followed by clinical examination and specimen collection
for different STIs. 118 SWs completed all aspects of the
survey. HIV testing was unlinked and anonymous.
Results: The mean number of different sexual partners of
SWs per day was five. 94.9% reported consistent condom
use with the clients. 58.5% of SWs had no symptoms
related to STDs at the time of examination. Reported
symptoms included lower abdominal pain (19.5%), abnormal
vaginal discharge (12.7%), painful sexual intercourse
(12.7%), painful micturition (11.0%), itching around the
genital area (10.2%), and genital ulcer (5.9%). The prevalence
of STI "syndromes" were vaginal discharge syndrome 51.7%, pain
in lower abdomen 19.5%, enlarged inguinal lymph nodes 11.9%,
and genital ulcer 5.9%. Based on the laboratory reports
(excluding HIV tests), 62 (52.5%) SWs did not have any of
the four tested STIs. Prevalence of laboratory confirmed
STIs were syphilis 22.7% (based on reactive syphilis
serology tests), gonorrhoea 16.9%, genital chlamydial
infection 8.5%, and trichomoniasis 14.4%. HIV prevalence
was 43.2%. The performance of Indian recommended
treatment guidelines for vaginal discharge syndrome (VDS) and
genital ulcer syndrome (GUS) against aetiological diagnosis
was poor.
Conclusion: Prevalence of different STIs and HIV among the
FSWs in the Surat red light area is high despite high
reported condom use with clients. Syndromic case
management is missing a large number of asymptomatic
cases and providing treatment in the absence of disease.
Therefore, it is necessary to explore alternative
strategies for control of STIs in female sex workers. STI services
need to be improved.
Keywords: STI prevalence; syndromic diagnosis; sex
workers; HIV; India
Sexually transmitted infections (STIs), including HIV, continue
to present major health, social, and economic problems in the
developing world, leading to considerable morbidity,
mortality, and stigma.1 The prevalence rates
apparently are far higher in developing countries where
STD treatment is less accessible.2
Association of HIV and STIs has led to common control strategies
for both.2–5 The change in the incidence and
prevalence of HIV is extremely difficult to detect.
However, the prevalence and incidence of some STIs, which
are curable, changes quickly, and can be used as a proxy
marker for changes in sexual behaviour and, ultimately,
the HIV incidence.6
Sex workers are one of the core groups for transmission of STDs
and HIV as a "bridge group" to the general population.
Accordingly, highest priority is given to this group in
targeted intervention for prevention of HIV/AIDS. A
comprehensive baseline situational analysis of the STI
problem in the programme area is required to monitor
targeted intervention. It is necessary to know the
prevalence of common STIs, such as gonococcal, chlamydial infection,
and syphilis, and the proportions of asymptomatic infections
to design effective STI services. To design locally
appropriate syndromic treatment guidelines, knowledge
about the aetiology of symptoms of STIs is essential,
with the help of sensitivity analysis.
The World Health Organization (WHO) has placed the emphasis
on a syndromic approach for case measurement and management,
particularly in high prevalence areas having inadequate
laboratory facilities, trained staff, and transport
facilities.2 While the risk assessment for the
management of reproductive tract infection has many
limitations, further work on risk assessment and
prevalence based screening studies is necessary to evaluate
the performance of syndromic management.7
Surat is an important commercial and industrial city in India.
This study was conducted among the sex workers of a red light
area (RLA) in Surat, where a DFID funded project—Partnership
in Sexual Health—has been operational since 1998 by the
community medicine department of Government Medical College,
Surat. The present study is a baseline STD prevalence study
that will help in situational analysis, future monitoring of
intervention programmes for STI control, and evaluation of
syndromic management.
The overall objective of the study was to find out point
prevalence of selected STIs and HIV among female SWs of
the Surat RLA. The specific objectives were to measure
the prevalence of STI syndromes and other STIs clinically
and selected STIs and HIV by laboratory investigations,
and to evaluate the performance of syndromic case
management (Indian guidelines) against the gold standard
of aetiological diagnosis for STIs in this group.
METHODS
It was a cross sectional study. The protocol for implementation
was developed and finalised after review by experts and
stakeholders at a planning workshop.
Ethical review
Locally, an ethics committee reviewed the protocol and the
recommendations of the committee were included in the
final protocol. The protection of human subjects
committee of Family Health International (FHI) approved
the study protocol. Free and voluntary informed consent
was obtained from all the participants, retaining their right
to withdraw at any time. Personal privacy and confidentiality
was respected at all the times.
The staff was trained appropriately before the implementation
and a trial run was conducted. National and international
experts on STD and microbiology were the resource people
for the training workshop. Based on the experience of the
trial run, some modifications were made for the final
survey.
Sample size
The SWs live in different ethnic clusters. Based on factors
such as place of origin, language spoken, etc, participants
were recruited from each of these clusters. Baseline data on
the prevalence of STIs among the SWs in Surat RLA were not
available, so it was difficult to calculate the accurate
sample size. It was also difficult to prepare their list,
so out of 500–600 SWs working in this area, coverage of
about 200 SWs (one third) was considered a sufficient
representative sample. However, because of the temporary
migration of sex workers, only 124 SWs could be enrolled
in this study. Out of this number, 118 completed all
aspects of the study and the rest were not recruited for
various reasons like refusal to undergo clinical examination,
refusal to provide specimen, etc.
Mobilisation of SWs for
the survey
A health camp approach was taken to recruit the participants.
Equal opportunity was offered to all of them to participate
in the study. By group meetings conducted with mausis (madams)
and peer educators, a consensus was developed for the needs
and importance of the clinical health check up, laboratory
investigations, and prompt treatment. This facilitated
motivation for participation by SWs. The rapport of the
social workers and social scientists in the project with
the peer leaders of the area was instrumental in the
mobilisation of the participants. Treatment for the symptomatic
cases and a relief following the same was the additional
motivation for those who were reluctant. A woman friendly
service and hospitality were further incentives for
participation. The survey was conducted from February to
September 2000 at the STD clinic established for ongoing
diagnostic and therapeutic services to the SWs and the
community, under the PSH project in the RLA.
Clinic procedure
Forms for physical examination and for the laboratory investigation
had the same identification (ID) number for a participant.
After informed consent in the presence of a witness,
general information about the consenting participant was
recorded in the structured questionnaire designed by FHI.
This was followed by clinical examination and specimen
collection in an examination room, by a
dermatovenereologist, gynaecologist, and pathologist.
STIs screened and
laboratory tests employed
Syphilis testing was done using the rapid papain resin (RPR)
test (Spinreact Reactivos. Spinreact, Spain) and confirmed by
the Treponema pallidum haemagglutination assay (TPHA)
test (Human, Human Gesellschaft fur Biochenica and
Diagnostics mbH, Germany) following the instructions of
the manufacturer. Sera positive for both RPR (at one in
eight dilution) and TPHA test indicated the presence of
active syphilis infection.
Gonorrhoea was diagnosed using a standard Gram stained smear
of an endocervical swab culture and Pace2 GC assay.
Neisseria gonorrhoeae (NG) was cultured in modified
Thayer-Martin medium (Himedia, Himedia Laboratories
Limited, Mumbai, India) from endocervical specimens and
inoculated at the clinic. One part of the swab was
subjected to inoculation on MH blood agar and another on
MTM medium in "Z" pattern. Inoculated plates were
transferred to an incubator at 36°C in an anaerobic jar
containing a carbon dioxide gas pack (BBL, Difco). Plates were
examined and colony characteristics of any growth looked for
after 24 hours and 48 hours of incubation. An oxidase test was
done on small pinpoint greyish colonies, characteristic of
gonococci. Gram stain was done on all oxidase positive
colonies and the carbohydrate degradation test was done
for confirmation. Isolates fermenting glucose but not
maltose and lactose were considered as confirmed N
gonorrhoeae and were used for further sensitivity
testing. For antibiotic sensitivity testing, the disc diffusion
method was followed. In addition, Pace-2 GC and CT assays
(Gen-probe Incorporated, 9880 Campus Point Drive, San
Diego, CA, USA) for NG and genital chlamydial infection
were performed on endocervical specimens at Biocare
Diagnostics and Research Centre (BDBRC), Ahmedabad for
the first time in India.
For diagnosing Trichomonas vaginalis, wet mount microscopy
and culture in the Whittington media (Himedia HiMedia
Laboratories Limited, Mumbai, India) were done on
specimens collected from the posterior vaginal fornix.
All these tests (except Pace 2 GC and CT assays) were
done in the Khandwala clinical laboratory, a private
laboratory in Surat.
For HIV double ELISA tests were done using kits from Biosign
(Princeton BioMeditech Corp for Premier Medial Corp, USA) and
Lab Systems (Lab Systems, Helsinki, Finland), at the
microbiology department of BJ Medial College, Ahmedabad,
which is the nodal centre for HIV testing in the state of
Gujarat. Two positive ELISA tests were considered
positive for HIV.
Additional specimens from 10 participants were sent to BDBRC
for repeats of some of the laboratory tests (RPR test, TPHA
test, Gram stain, and culture for gonorrhoea) for cross
checking; there was good matching between the results of
the two laboratories.
Data entry and analysis
The EPI-INFO
package (software) was used to design the questionnaire
and for data entry, record, and data analysis. The proportions
were calculated for various syndrome and disease prevalence.
Sensitivity, specificity, and PPV of various syndromes were
calculated. Confidence intervals for STI prevalence were
calculated for future monitoring.
RESULTS
Sociodemographic profile
The age of SWs ranged from 16 to 50 years, the mean age being
28.5 years. The majority of them (about two thirds) were below
the age of 30 years, which included about 5.1% below the age
of 20 years (table 1).
In all, 80.5% of them had never attended a school. Except
for three, all of the SWs reported migrating from other
states and about 33.1% from another country (Nepal). Some
59.3% reported that they were married; however, only three
were living with their husband; 94.9% of them reported the use
of condom all the times; 90% had more than two sexual partners
(clients) per day. The range in number of different partners
per day varied from two to 25, the mean being five clients per
day.
Table 1 Age groups and prevalence of signs, symptom, and
syndromes related to STI in sex workers
|
Syndromes/variables |
No of SWs (n=118) |
% |
|
|
|
Age group (years): |
|
|
|
16–20 |
6 |
5.1 |
|
21–25 |
35 |
29.7 |
|
25–30 |
41 |
34.7 |
|
31–35 |
23 |
19.5 |
|
More than 36 |
8 |
6.8 |
|
Age not reported |
5 |
4.2 |
|
Prevalence rate of present symptoms* |
|
|
|
No symptom |
69 |
58.5 |
|
Pain in lower abdomen |
23 |
19.5 |
|
Abnormal vaginal discharge |
15 |
12.7 |
|
Painful sexual intercourse |
15 |
12.7 |
|
Painful micturition |
13 |
11.0 |
|
Itching around genital area |
12 |
10.2 |
|
Genital ulcer |
7 |
5.9 |
|
Swelling in groin |
3 |
2.5 |
|
Prevalence rate of signs on external
genital examination: |
|
Warts |
13 |
11.0 |
|
Enlarged lymph nodes |
14 |
11.9 |
|
Depigmentation |
5 |
4.2 |
|
Ulcer |
5 |
4.2 |
|
Scabies |
3 |
2.5 |
|
Discharge |
5 |
4.2 |
|
Inflammation of vulva |
3 |
2.5 |
|
Signs as per speculum examination: |
|
|
|
Discharge from vagina |
61 |
51.7 |
|
Abnormal ectocervix |
32 |
27.1 |
|
Abnormal vaginal wall |
16 |
13.6 |
|
Cervix bleeding on touch of |
15 |
12.7 |
|
Ulcer on cervix/vaginal wall |
3 |
2.5 |
|
Prevalence rate as per syndromic
diagnosis: |
|
Genital discharge syndrome |
61 |
51.7 |
|
Genital ulcer syndrome |
7 |
5.9 |
|
Lower abdominal pain |
23 |
19.5 |
|
Enlarged inguinal lymph nodes |
14 |
11.9 |
|
|
|
*Some had more than one symptom(s). |
|
One
person had ulcer diagnosed on both external and PS
examination. |
|
Prevalence of STD syndromes
Sixty nine (58.5%) SWs did not report genitourinary complaints
spontaneously. Among the 49 who reported, 24 had one symptom,
13 had two symptoms, six had three symptoms, four had four
symptoms, and two had five symptoms. Pain in the lower
abdomen was the most common complaint (19.5%), followed
by vaginal discharge (12.7%) (table 1);
46.7% gave no past history of symptoms suggestive of STD.
Seventy two (61.0%) had a history of any of the specific
symptoms mentioned in the table 1;
56(47.5%) had vaginal discharge, 35 (29.7%) had pain in
lower abdomen, and 34 (28.8%) had had genital sore/ulcer
in the past.
On external genital examination 52 (44.1%) SWs had one or more
clinical sign suggestive of an STD. The most common syndromic
diagnosis was abnormal vaginal discharge syndrome (VDS)
(51.7%), followed by pain in the lower abdomen (19.5%),
enlarged inguinal lymph nodes (11.9%), and genital ulcer
syndrome (GUS) (5.9%) (table 1).
Prevalence of laboratory
confirmed STIs
The prevalence of STIs and HIV based on the laboratory screening
is shown in table 2.
The prevalence of syphilis based on RPR and TPHA positive
tests was 22.9%. The prevalence of other STIs was
gonorrhoea (by GC culture) 16.9%; genital chlamydial infection
8.5%; and trichomoniasis 14.4%. In all, 47.5% had one or more
of these four STIs. No strain was resistant to any of the
antibiotics tested for sensitivity, yet the sensitivity
was moderate in 10–25% of cases for various tested
antibiotics. Cervicitis (presence of NG and/or CT) was
found in 20.3%, while cervicitis and/or trichomoniasis
was present in 32.2%. The seroprevalence of HIV was
43.2%.
Table 2 Laboratory findings: prevalence of STIs among SWs
(N=118)
|
|
|
Results (positive/reactive)
|
|
|
STI |
Test performed |
No |
% |
95% CI |
|
|
|
Syphilis |
1 RPR test |
35 |
29.7 |
|
|
|
2 TPHA test |
51 |
43.2 |
|
|
|
3 Both RPR and TPHA test |
27 |
22.9 |
15 to 30 |
|
Gonorrhoea |
1 Gram stain |
18 |
15.3 |
|
|
|
2 Culture in MTM media |
20 |
16.9 |
10 to 24 |
|
|
3 Pace 2 GC assay |
12 |
10.2 |
|
|
Chlamydia |
Pace 2 CT assay |
10 |
8.5 |
3 to 14 |
|
Trichomoniasis |
1 Wet mount microscopy |
16 |
13.6 |
|
|
|
2 Culture in Whittington media |
17 |
14.4 |
8 to 21 |
|
HIV |
Double ELISA test (HIV 1 and 2) |
51 |
43.2 |
34 to 52 |
|
NG/CT cervicitis |
Culture for NG and/or Pace 2 CT |
24 |
20.3 |
11 to 30 |
|
NG/CT cervicitis and/or trichomoniasis |
Culture for NG/ TV and/or Pace 2 CT |
38 |
32.2 |
21 to 43 |
|
Performance of "syndromes"
Table 3
shows the sensitivity, specificity, and PPV of Indian
syndrome management guidelines for VDS and GUS. The sensitivity
of VDS to detect trichomonal infection was 88.2%, chlamydial
infection 70%, and gonococcal infection 60%. However, the
specificity for all these infection was only around
50–55%. PPV was very low, ranging from 11.5% for
chlamydia and 19.7% for gonococci to 24.6% for
trichomonas. Sensitivity, specificity, and PPV of VDS for
cervicitis (NG/CT) were 54.2%, 48.9%, and 21.3% respectively;
while for the presence of both cervicitis and/or
trichomoniasis they were 65.8%, 55.0%, and 41.0%,
respectively. The sensitivity and specificity of VDS for
cervicitis (NG/CT) was lower and PPV was higher than
those for individual infections. When trichomoniasis is
also combined with cervicitis, sensitivity and specificity
of VDS is not changed significantly, but the PPV more than
doubles. Conversely, the sensitivity of GUS to detect
syphilis was 14.8% only, but the specificity was very
high, 96.7%, and the PPV was 57.1%.
Table 3 Performance of various syndromes
and tests
|
Syndrome/infection/test |
No of SWs |
No of infected |
No of cases detected by syndrome |
Sensitivity (%) |
Specificity (%) |
PPV* (%) |
|
|
|
Vaginal discharge syndrome for: |
|
|
|
|
|
|
|
Trichomonas |
118 |
17 |
15 |
88.2 |
54.5 |
24.6 |
|
Chlamydia |
118 |
10 |
7 |
70.0 |
50.0 |
11.5 |
|
Gonococci: |
|
|
|
|
|
|
|
Based on culture |
118 |
20 |
12 |
60.0 |
50.0 |
19.7 |
|
Based on Pace2 |
118 |
12 |
7 |
58.3 |
49.1 |
11.5 |
|
Gonococcal and/or chlamydial
cervicitis |
118 |
24 |
13 |
54.2 |
48.9 |
21.3 |
|
Gonococcal and/or chlamydial
cervicitis and/or trichomonas vaginitis |
118 |
38 |
25 |
65.8 |
55.0 |
41.0 |
|
Genital ulcer syndrome for: |
|
|
|
|
|
|
|
Syphilis |
118 |
27 |
4 |
14.8 |
96.7 |
57.1 |
|
Wet mount for: |
|
|
|
|
|
|
|
Trichomonas |
118 |
17 |
13 |
76.5 |
97.0 |
81.3 |
|
|
|
*PPV = positive predictive value. |
|
DISCUSSION
There is a dearth of information regarding the epidemiology
of STDs in India for many reasons such as recent recognition
of STDs as a major public health problem, stigma and
discrimination associated with the STDs, lack of
interdepartmental coordination for studies, poor
attendance of STD patients at the public clinics and
academic institutions, availability of limited diagnostic
facilities, etc. This in-depth clinical research offers an important
insight into the burden and pattern of STIs in this core group
of SWs and on syndromic management of STIs.
The majority of SWs are illiterate and from outside Gujarat.
The proximity to Mumbai and history of migration for sex work
(mostly to Mumbai) is important, as the reported HIV level in
SWs in Mumbai is more than 50%.8
We found a very high level of STIs and HIV in a population of
sex workers. Though only 12.7% complained of vaginal
discharge, up to 51.7% were found to have abnormal
vaginal discharge on examination. This implies that the
awareness to recognise symptoms of STIs and health
seeking behaviour of female SWs needs to be improved.
In the present study of SWs, 41.2% had one or more symptoms
and 43.7% had one or more clinical signs suggestive of STD.
In Calcutta, 59% of the SWs were found to have an STD.9
The most common syndromic diagnosis in the present study was
VDS (51.7%), which is lower than that found (83%) in a similar
study of SWs at Ahmedabad, done at the same time with the same
methodology (unpublished report, Jyotisangh, Ahmedabad).
Active syphilis was the most common infection among SWs in the
present study. It has risen from 18.5% in a 1992 study10
done in 108 SWs in the same area (using VDRL test) to
29.7% based on RPR and 22.9% (based on RPR and TPHA test)
in the present study. It is comparable with 24.2%
prevalence found in the Ahmedabad study done by
Jyotisangh. A 43% prevalence of TPHA positivity found in
this study indicates the presence of past or present
syphilis infection, which is a matter of concern in the context
of HIV transmission.
The prevalence of gonorrhoea confirmed by the culture method
was 16.9%, which is comparable with that found in study done
by Jyotisangh at Ahmedabad (19%); while it is higher than in
the Kolkata study11 (9.1%), done among a high risk
group from a red light area. The prevalence of gonorrhoea
in SWs had varied from 4–31% in Latin America, 8.5–42% in
Asia, and 20–50% in Africa.12 As no resistant
strain of gonococci against tested antibiotics was found
in this study, any of the antibiotics in appropriate
doses are useful to control the gonococci. Not using a
condom with their regular/consistent partner may be one
of the causes for the higher prevalence.
Genital chlamydial infection detected by the Pace 2 test was
found in 8.5% here, while in Ahmedabad (Jyotisangh) it was
almost double (17%). Gonococcal and/or chlamydial
infection (cervicitis) was present in 20.3% SWs. It has
been reported as 23.3% in Manila, 37.0% in Cebu
(Philippines),13 and 14% in Nicaragua.14 In
the present study prevalence of trichomoniasis (14.4%) is
much lower than that found in Ahmedabad (Jyotisangh)
(41%).
Seroprevalence of HIV has risen steeply from 18.5% in a study
done in the same area in 199210 to 43.2% in the
present study. In Mumbai, a similar rising trend among
SWs is reported, which was 1% in 1987, 18% in 1990, 34%
in 1992, 50% in 1995, and 62.8% in 1999.8
Effective intervention among the SWs was instrumental in
keeping the prevalence of HIV low among the SWs in Sonagachi.2
A similar declining trend in STD is observed in studies done
all over the world after different interventions in SWs.2
Surat is one of the badly affected cities in India. HIV
seroprevalence among attendees at an STI clinic was 26.0%
and 13% and at an antenatal clinic was 0.83% and 2.69%,
respectively during 1998 and 1999.15
On analysing specificity, sensitivity, and PPV of NACO
recommended treatment guidelines for syndromic management
against laboratory confirmed STI, it was observed that
the high sensitivity of VDS to trichomoniasis can be
effective in 88% of cases. However, another study16
had found that syndromic management had a minimum effect
on its endemicity even at a high level of coverage. Alternatively,
screening had been found to be the most efficient method of
control.16 Use of the wet mount method in a case of
VDS can increase the specificity and PPV for detecting a
case of trichomonas infection (table 3).
Syndromic management based on VDS missed about 30–40%
cases of genital chlamydia or gonococcal infection and it led
to treatment in the absence of infection of chlamydia in about
90% and of gonococci in 80% cases of VDS (table 3).
Among those having no infection, 45–50% were labelled as
having infection and treated for VDS. Thus, syndromic
management for individual cervicitis is not very useful,
as is reported by others.17–20
Though the cardinal sign for NG and CT infection, according
to syndromic case management guidelines,21 is
discharge from the cervix, if the risk assessment is
positive (that is, if the sexual partner has urethral
discharge or genital ulcer—a criterion which is rather
difficult to follow in case of female SWs because of high
rate of partner change), all women with vaginal discharge
should be treated for NG and CT infections, as the
sensitivity of VDS was 54% for laboratory confirmed cases
of cervicitis, while syndromic diagnosis of cervicitis was a
sensitivity of only 41.7%. Simultaneous treatment for
trichomoniasis will cover 65.8% cases having any of these
three STIs and in such cases the higher PPV will justify
the cost of treatment, in spite of poor performance of
syndromic management.
Though specificity of GUS is high, syndromic management based
on GUS may miss about 85% of cases having active infection,
and will lead to treatment of ulcers in 43% of cases in the
absence of syphilis infection. Such a situation leads to an
obvious financial burden of unindicated treatment and deprives
asymptomatic cases of treatment.
Even though syndromic case management is recommended for all
the groups including the female SWs in India, the present
study reveals that it is of limited use in GUS and VDS in
the sex worker population. Quick and inexpensive
diagnostic tests, which are being developed for primary
healthcare providers can help to solve both of these
problems.1
The control of STIs among the core group is crucial, as it has
been estimated that cost per DALY (disability adjusted life
years) saved by treating the classic STIs was very high in the
non-core group compared to core group and that a policy of
targeting the "core" averts many more new infections of
STIs than would have been averted by a policy directed at
the non-core group.22 So investment in treatment of SWs
(core group) is justified.
Despite the high level of reported condom use with clients and
provision of centre based STI care for several months as a
part of the intervention, the prevalence of STIs was high
in this study group. The presence of a higher rate of
asymptomatic infection adds to the risk. It is necessary
to try to test alternative approaches such as periodic
presumptive therapy of common STIs with DOT, because this
will not only boost up the ongoing efforts of STI control
in the target group but also help in HIV control. Such
efforts have been found to be useful in reducing STD prevalence.
In a study done in a rural African population, mass treatment
combined with improved treatment services has been found to
lead to a rapid and sustained fall in HIV incidence.23
Alternatively, regular clinical and laboratory screening
for different STIs may be tried. In the Abidijan study,24
a South African mining community study,25 and
the Mwanza trial26 it was observed that there
was significant reduction of HIV incidence and other STIs
among female SWs who received a comprehensive intervention of
health education, condom distribution, and periodic screening
and treatment. Also, a comparative study of cost effectiveness
of syndromic management, screening based management, and mass
treatment can be helpful to determine a more effective
approach to reduce STI and HIV infection in the female
SWs of Surat.
The limitations of this study are: (1) the participation of
those having symptoms and expecting treatment and results may
be higher leading to selection bias; (2) the healthy worker
effect cannot be ruled out because of non-inclusion of the SWs
who had already left the work because of ill health; and (3)
the study did not include the FSWs operating outside the RLA.
Little information is known on the behaviour and STI level in
this category.
ACKNOWLEDGEMENTS
We are grateful to DFID, UK, for providing financial assistance.
The authors would like to thank all the FSWs, consultants, and
individuals who had cooperated in this study. The views
expressed in this paper are those of the authors and do
not necessarily reflect the views of FHI or DFID.
CONTRIBUTORS
VKD, planning, implementation, analysis, and documentation
of the study as an administrator and technician in charge of
the project; JKK, implementation of the study in the field and
recording of data as project co-investigator; HGT, analysis,
documentation, literature search, and review; DNU, clinical
examination and treatment of participants as a venereologist;
BRK, laboratory investigations (collection, analysis, and
interpretation); BKK, project planning, technical
assistance.
REFERENCES
- Lande R. Controlling sexually
transmitted diseases. Population Reports, Series L, No 9.
Baltimore, MA: Johns Hopkins School of Public Health, Population
Information Programme, June 1993.
- Adler M, Foster S, Grosskrurth H,
et al. Sexual health and health care, sexually transmitted
infections. Guidelines for Prevention and Treatment Health and
Population Occasional Paper DFID, London.
- Nayyar A. Questions and answers on
reproductive tract infections and sexually transmitted infections.
Population Council, UNFPA.
- Plummer FA, Simonsen JN, Cameron DW,
et al. Cofactors in male female sexual transmission of HIV
type I. J Infect Dis 1991;163233–9.
- De Vincenzi I. European study group
on hetero-sexual transmission of HIV a longitudinal study of human
immuno-deficiency virus transmission by hetero-sexual partner.
N Engl J Med 1994;33341–63.
- AIDSCAP. Evaluation tools,
introduction to AIDSCAP evaluation, outcome and impact evaluation.
Family Health International 1993:14.
- Dallabetta GA, Gerbase AC, Holmes KK.
Problems, solutions and challenges in syndromic management of
sexually transmitted diseases. Sex Transm Infect 1998;74(Suppl
1):S1–11.
- Bhave G, Wagle V, Desai S, et al.
HIV surveillance and prevention, II interventional congress of
AIDS in Asia and Pacific, New Delhi, November 1992. Abstract No C
401.
- World Health Organization. Management
of sexually transmitted diseases at district and PHC levels. WHO
Regional office for South-East Asia, New Delhi, Pub No 25, 1997.
- Kosambiya JK. A sero-epidemiological
study of HIV in Surat cityRisk behavioural approach. The
dissertation submitted to the South Gujarat University, Surat for
the Degree of Doctor of Medicine (P & SM). Department of P & SM,
Government Medical College, Surat, 1993.
- Thawani G, Bhatia VN, Jana S. Herpes,
cytomegalovirus and other STDs in high risk group. Indian J Sex
Transm Dis 1996;1711–14.
- World Health Organization. WHO
Technical Report 736. WHO expert committee on veneral disease
and treponematoses. Geneva: WHO, 1986.
- Wit, Mesiola V, Manalastas R, et
al. Syndromic approach to detection of gonococcal and
chlamydial infections among female sex workers in two Philippine
cities. Sex Transm Infect 1998;74(suppl 1) S118–22
- Herrmann B, Espinoza F, Villegas RR,
et al. Genital chlamydial infection among women in
Nicaragha. Validity of direct fluorescent antibody testing ,
prevalence, risk factors and clinical manifestation. Genitourin
Med 1996;7220–6.
- NACO. HIV Sentinel Surveillance
Report-August-October-1999. National AIDS Control Organization,
Ministry of Health and Family Welfare, Government of India. Nirman
Bhawan, New Delhi, 2000.
- Bowden FJ, Garnett GP, Trichomonas
vaginalis epidemiology; parameterising and analysing a model of
treatment interventions. Sex Transm Infect 2000;76:248–56.
- Vishwanath S, Talvar V, Prasad R,
et al. Syndromic management of vaginal discharge among women
in a reproductive health clinic in India. Sex Transm Infect
2000;76:303–6.
- Bogaerts J, Ahmed J, Akhter N, et
al. Sexually transmitted infections in a basic health care
clinic in Dhaka, Bangladesh. Syndromic management for activities
is not justified. Sex Transm Infect 1999;75:437–8.
- Sloan NL, Winikoff B, Harberland N,
et al. Screening and syndromic approaches to identify
gonorrhoea, and chlamydial infection among women. Study Fam
Plann 2000;31:55–8.
- Van dam CJ, Becker KM, Ndowaf, et
al. Syndromic appraoch to STD case management; where do we go
from here? Sex Transm Infect 1998;74(suppl):s175–8.
- NACO. Simplified STI and RTI
Treatment Guidelines (Flow charts). National AIDS Control
Organization, Ministry of Health and Family Welfare, Government of
India.
- Over M, Piot P. Human immuno-deficiency
virus and other sexually transmitted diseases in developing
countries; public health importance and priorities for resource
allocation. J Infect Dis 1996;174(Suppl 2)S162–75.
- Korenromp EL, Van vliet C, Grosskurth
N, et al. Model-based evaluation of single round mass
treatment of sexually transmitted disease for HIV control in a
rural African population AIDS 2000;14:573–93.
- Ghys Peter D, Diallo M,
Ettiegne-Traore V, et al. Effects of interventions to
control sexually transmitted diseases on the incidence of HIV
infection in female sex workers. AIDS 2001;151421–3.
- Steen R, VuylstekeB, DeEoito T, et
al. Evidence of declining STD prevalence in a South African
mining community following core group intervention. Sex Transm
Dis 2000;27:1–8.
- Grosskurt H, Gray R, Hayes RM, et
al. Control of sexually transmitted diseases for HIV-1
preventionunderstanding the implications of the Mwanza and Rakai
Trials. Lancet 2000;3551981–7.
|